Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Chemphys Placement Participation Funds Received

by admin January 28, 2025
January 28, 2025
Chemphys Placement Participation Funds Received

Galan Lithium Limited (ASX: GLN) (Galan or the Company) is pleased to advise that it has received proceeds from Latam Resources Pty Limited (Latam), an Affiliate of Chengdu Chemphys Chemical Industry Co., Ltd (Chemphys) in relation to the share placement (Placement) announced by the Company on 10 September 2024 and subsequently approved by shareholders at the Galan Annual General Meeting held on 15 November 2024. Chemphys agreed to subscribe for US$3 million worth of shares under the terms of the Placement.

Funds received from Latam will be applied by Galan towards ongoing Phase 1 operations at Hombre Muerto West (HMW), as parties continue to work towards finalising an offtake prepayment facility targeted financial close during the first quarter of 2025.

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Top Altcoins to Watch in 2025: An Investor’s Guide
next post
Newmont Completes Divestitures With US$425 Million Sale to Discovery Silver

Related Posts

LaFleur Minerals Provides Supplemental Disclosure Related to BullRun...

February 28, 2025

Murchison South Increases to 67koz Gold Across Two...

May 13, 2025

Exploration Target at Golden Crown to Focus on...

May 27, 2025

Coelacanth Announces Q1 2025 Financial and Operating Results

May 29, 2025

Crypto Market Update: GENIUS Act Becomes First Federal...

July 21, 2025

Crypto Market Recap: Coinbase Acquires Liquifi, Tether to...

July 3, 2025

Second Amendment to Black Mountain Purchase Option

March 28, 2025

Investing in Uranium ETFs: 9 Options for Uranium...

May 10, 2025

Sarama Resources Advances Mt Venn Gold Project Acquisition

February 27, 2025

Prismo Metals Discovers Two Separate Mineralized Veins at...

August 28, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved